Your session is about to expire
← Back to Search
Health Care Access Interventions for Taxi Drivers
N/A
Waitlist Available
Led By Francesca Gany, MD, MS
Research Sponsored by Memorial Sloan Kettering Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
No Placebo-Only Group
Summary
This trial is comparing the effectiveness of 3 different approaches to help taxi drivers go to important medical appointments and have a regular doctor. One approach is the usual health fair service and follow-up alone. The other two approaches add additional interventions of Navigation Case Management (NCM) or mobile text messaging (mTECH) and Taxi health Improvement Promoter (TIP). The trial will help researchers find out whether the different approaches are better, the same as, or worse than the usual approach.
Who is the study for?
This trial is for male taxi drivers aged 21-85 in NYC who speak English, Bengali, Urdu, Spanish, or French. They must own a cell phone capable of texting and lack a regular doctor. Participants should not have had an annual physical outside of work requirements within the last year and plan to stay in NYC for at least one more year.
What is being tested?
The study tests if adding Navigation Case Management (NCM), mobile text messaging (mTECH), and Taxi health Improvement Promoter (TIP) to usual follow-up improves healthcare access for taxi drivers. It aims to determine whether these interventions help drivers attend medical appointments and maintain regular healthcare.
What are the potential side effects?
Since this trial involves questionnaires and communication-based interventions rather than medications or invasive procedures, there are no direct medical side effects expected from participation.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Number of drivers that have a primary care provider (pcp)
Side effects data
From 2023 Phase 2 trial • 45 Patients • NCT0228035673%
Urinary frequency
69%
Urinary urgency
58%
Erectile dysfunction
18%
Fatigue
16%
Urinary incontinence
13%
Urinary tract obstruction
13%
Urinary tract pain
11%
Rectal hemorrhage
11%
Renal and urinary disorders - Other, specify
9%
Diarrhea
9%
Proctitis
100%
80%
60%
40%
20%
0%
Study treatment Arm
Radiation Therapy in Combination With Brachytherapy
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Health Fair + Taxi Health Improvement PromotersExperimental Treatment1 Intervention
Health Fair standard services Follow-up call or further in-person assistance within one day for urgent follow-up, or call within two weeks for regular needs. Three call attempts.
Taxi health Improvement Promoters (TIPs)
* Weekly check-ins with each participant, in person or by phone, about scheduling of, and attendance at, primary care appointments along with other health or study questions Mosio Text Messaging Program
* Send primary care provider recommendations to participant up to three times
* Two pre-appointment reminders \& one post-appointment check-in
* Twice weekly health promotion reminders after primary care appointment
Group II: Health Fair + Navigator Case ManagementExperimental Treatment1 Intervention
• Follow-up call or further in-person assistance within one day for urgent follow-up, or call within two weeks for regular needs. Three call attempts.
Navigator Case Management by trained staff
* Tailored assistance for any health needs a minimum of once a month 12 months. Assistance includes pre-appointment reminder calls, post-appointment follow up calls, and health promotion reminders.
* NCM case management will continue follow-up at a minimum of once per month or as requested by the participant for the study duration and will consistently offer appointment reminders and follow-ups.
Group III: Health Fair Alone (Control)Active Control1 Intervention
No Follow Up Participant does not require referrals or assistance and was not advised to see a provider in the next three months.
Regular follow-up call within two weeks of health fair by IHCD intern or staff. Participant has abnormal values, requires referrals or assistance or was advised to see a provider in the next three months.
Up to 3 call attempts to get participant into needed care. Further contact only by participant request.
Urgent follow-up call or in-person assistance within 1 day of health fair by IHCD intern or staff Participant advised to seek urgent care within one week.
Three total call or in-person attempts to get participant into needed care. Further contact only by participant request The follow up call attempts may extend up to 3 months past the date of health fair to complete any needs the driver may have.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
questionnaires
2008
Completed Phase 2
~4390
Find a Location
Who is running the clinical trial?
SOUTH ASIAN COUNCIL FOR SOCIAL SERVICESUNKNOWN
Memorial Sloan Kettering Cancer CenterLead Sponsor
1,976 Previous Clinical Trials
598,744 Total Patients Enrolled
Francesca Gany, MD, MSPrincipal InvestigatorMemorial Sloan Kettering Cancer Center
9 Previous Clinical Trials
3,039 Total Patients Enrolled